Glaukos

Sr. Market Access Analyst II

Glaukos$100K — $130K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree required; advanced degree preferred.
  • 8+ years of experience in market access analytics, pricing, reimbursement, HEOR, or related healthcare analytics functions.
  • Deep understanding of payer dynamics, reimbursement, and channel strategy.
  • Experience influencing senior leaders through data-driven recommendations.
  • Strong analytical, modeling, and problem-solving skills.
  • Proven ability to build and scale analytics capabilities that drive business impact.

Responsibilities

  • Lead market access analytics across pricing, contracting, reimbursement, and channel strategy.
  • Develop scenario models and business impact assessments for strategic decision-making.
  • Provide executive-level insights on access performance, risks, and opportunities.
  • Define and track key performance indicators for payer access and patient journey performance.
  • Lead analytics on Buy and Bill and Specialty Pharmacy channel optimization.
  • Analyze HUB, payer, and field reimbursement data to identify trends and access barriers.
  • Build scalable reporting, analytics, and data governance capabilities across data sources.

Benefits

  • Opportunity to work remotely.
  • Involvement in shaping pricing and access strategies for a growing company.
  • Collaboration with senior leadership to inform critical business decisions.
  • Impact on long-term commercial success and patient access.
  • Cross-functional partnerships enhance professional growth opportunities.
Full Job Description
Job Description

Glaukos - Senior Market Access Analyst II (U.S. Remote)

Join a growing Market Access team where you'll help shape pricing, reimbursement, contracting, and channel strategy through advanced analytics and strategic insights. This highly visible role partners closely with senior leadership to drive data-informed decisions that improve patient access and support long-term commercial success.

What You'll Do
  • Lead enterprise-wide market access analytics across pricing, contracting, reimbursement, and channel strategy.
  • Develop scenario models and business impact assessments to support strategic decision-making.
  • Provide executive-level insights on access performance, risks, and opportunities.
  • Define and track key performance indicators related to payer access, reimbursement, and patient journey performance.
  • Lead analytics supporting Buy and Bill and Specialty Pharmacy channel optimization.
  • Analyze HUB, payer, and field reimbursement data to identify trends and access barriers.
  • Build scalable reporting, analytics, and data governance capabilities across multiple data sources.
  • Partner cross-functionally with Commercial, Market Access, Finance, Patient Services, and other stakeholders to support strategic planning and business growth.

What You Bring
  • Bachelor's degree required; advanced degree preferred.
  • 8+ years of experience in market access analytics, pricing, reimbursement, HEOR, or related healthcare analytics functions.
  • Deep understanding of payer dynamics, reimbursement, and channel strategy.
  • Experience influencing senior leaders through data-driven recommendations.
  • Strong analytical, modeling, and problem-solving skills.
  • Proven ability to build and scale analytics capabilities that drive business impact.

If you enjoy turning complex healthcare data into strategic insights that expand patient access and influence enterprise decisions, we'd love to hear from you.

#GKOSUS

#LI-Remote

About Glaukos

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent, its first MIGS device, in the United States in 2012 and is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. The company's second-generation MIGS device, the iStent inject, was approved by the FDA in June 2018. Glaukos is also developing a pipeline of innovative technologies in corneal health, including the recently acquired Microline surgical platform, as well as novel drug delivery technologies.
Learn more about Glaukos
Size
727 employees
Market Cap
$1.9 billion
Industry
Net Income
-$120.3 million
Founded
1998
5 Year Trend
+20.8%
Revenue
$224.9 million
NASDAQ

Similar Jobs

More Jobs at Glaukos

More Pharmaceuticals & Biotech Jobs

Find similar Sr. Market Access Analyst II jobs: